Solasta Ventures

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

Maxion Therapeutics raises £58m in Series A led by General Catalyst to advance KnotBody pipeline

17 Mar 2025

Maxion Therapeutics raises £58m in Series A led by General Catalyst to advance KnotBody pipeline

Maxion Therapeutics develops antibody-based KnotBody drugs targeting ion channels and GPCRs, advancing new treatments for inflammatory, pain and cardiovascular diseases with improved selectivity.

Solasta Ventures

- Life Sciences
solasta-ventures.com
Update Information

More venture news

Combat Medical
12 Mar 2026
Combat Medical raises a £2.6m Series A led by T&J Meyer Family Foundation for hard-to-treat bladder cancer
Series AHealth
Outpost
10 Mar 2026
Outpost unlocks £13m Series A led by Ribbit for cross-border payments and tax compliance infrastructure
Series AFintech
4 Mar 2026
Shellworks raises £11m Series A led by Alter Equity for biodegradable packaging made from microbial fermentation
Series ASupply Chain

Solasta Ventures

Investment Portfolio

Maxion Therapeutics raises £58m in Series A led by General Catalyst to advance KnotBody pipeline

More venture news

Combat Medical raises a £2.6m Series A led by T&J Meyer Family Foundation for hard-to-treat bladder cancer

Outpost unlocks £13m Series A led by Ribbit for cross-border payments and tax compliance infrastructure

Shellworks raises £11m Series A led by Alter Equity for biodegradable packaging made from microbial fermentation